Similarly, Wang et al. reported that immunotherapy-activated CD8+ T cells enhance tumor ferroptosis via IFN-γ-mediated downregulation of SLC3A2 and SLC7A11, further supporting the interplay between ferroptosis and immune activation 54. This evidence concerns the gene SLC3A2 and neoplasm.